Filing Details

Accession Number:
0001181431-14-030520
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-29 15:54:12
Reporting Period:
2014-08-27
Filing Date:
2014-08-29
Accepted Time:
2014-08-29 15:54:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352998 Igi Laboratories Inc IG Biological Products, (No Disgnostic Substances) (2836) 010355758
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
904778 A Don Sanders 600 Travis, Suite 5800
Houston TX 77002
No No No Yes
1184312 C James Gale 152 West 57Th Street, 19Th Floor
New York NY 10022
Yes No No No
1214494 T Benjamin Morris 600 Travis, Suite 5800
Houston TX 77002
No No No Yes
1269415 Life Sciences Opportunities Fund Ii Lp Carnegie Hall Tower
152 West 57Th Street, 19Th Floor
New York NY 10019
No No Yes No
1269417 Life Sciences Opportunities Fund Instittutional Ii Lp Carnegie Hall Towers
152 West 57Th Street, 19Th Floor
New York NY 10019
No No Yes No
1280952 Lof Partners Llc 126 East 56Th Street, 24Th Floor
New York NY 10022
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-08-27 455,257 $6.20 2,102,053 No 4 S Direct
Common Stock Disposition 2014-08-27 2,544,743 $6.20 11,749,808 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW"), the controlling member of the General Partner, and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
  2. These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, the controlling member of the General Partner, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.